Trading Signals: PFE Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Pfizer)
| PFE latest price $27.2611 (0.57%) ($26.8854 - $27.2868) on Wed. Dec. 3, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.02% (three month average) | | RSI | 77 | | Latest Price | $27.2611(0.57%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | PFE advances 0.8% a day on average for past five trading days. | | Weekly Trend | PFE advances 1.7% a week on average for past two weeks. | | Market Behavior | Value stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support PFE advance at 0% a week (0% probability)
XLV(63%) IVE(51%) VYM(51%) SPY(49%) IBB(48%) | | Factors Impacting PFE price | PFE will decline at least -0.51% in a week (0% probabilities).
VIXM(-19%) TLT(-13%) UUP(-5%) TIP(-4%) IGOV(-4%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.51% (StdDev 1.02%) | | Hourly BBV | 0 () | | Intraday Trend | 0.8% | | | | | |
|
| 5 Day Moving Average | $26.93(1.23%) | | 10 Day Moving Average | $26.54(2.72%) | | 20 Day Moving Average | $26.27(3.77%) | | To recent high | 0% | | To recent low | 15.6% | | Market Cap | $151.408b | | | | | | |
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. |